|
MTERFD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.132600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.102200E-03 |
| Normal-vs-Stage2 |
9.893600E-01 |
| Normal-vs-Stage3 |
4.384300E-02 |
| Normal-vs-Stage4 |
5.443400E-03 |
| Stage1-vs-Stage2 |
3.487900E-02 |
| Stage1-vs-Stage3 |
2.8681999997282E-07 |
| Stage1-vs-Stage4 |
6.13799999715781E-09 |
| Stage2-vs-Stage3 |
1.407990E-01 |
| Stage2-vs-Stage4 |
4.335700E-02 |
| Stage3-vs-Stage4 |
3.950000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.750000E-01 |
| Normal-vs-AfricanAmerican |
2.634800E-01 |
| Normal-vs-Asian |
5.925400E-01 |
| Caucasian-vs-AfricanAmerican |
2.980000E-01 |
| Caucasian-vs-Asian |
5.239600E-01 |
| AfricanAmerican-vs-Asian |
9.101600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.805800E-01 |
| Normal-vs-Female |
3.835600E-02 |
| Male-vs-Female |
2.264400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.473600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.127800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.231800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.481000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.547800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.325400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.337400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.825200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.614400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.503600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.022620E-03 |
| Normal-vs-Grade 2 |
1.981670E-03 |
| Normal-vs-Grade 3 |
1.727600E-01 |
| Normal-vs-Grade 4 |
4.354600E-04 |
| Grade 1-vs-Grade 2 |
2.835800E-03 |
| Grade 1-vs-Grade 3 |
2.75340000022162E-07 |
| Grade 1-vs-Grade 4 |
1.57820000401543E-08 |
| Grade 2-vs-Grade 3 |
3.27950000045263E-07 |
| Grade 2-vs-Grade 4 |
1.26090005103663E-09 |
| Grade 3-vs-Grade 4 |
6.402400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.67220000002466E-06 |
| Normal-vs-ccB subtype |
2.612200E-04 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.552400E-01 |
| Normal-vs-N1 |
2.401700E-04 |
| N0-vs-N1 |
3.979500E-03 |
|
|
